US Stock MarketDetailed Quotes
BGLC BioNexus Gene Lab
- 0.250
- -0.041-14.15%
Close Nov 25 16:00 ET
- 0.265
- +0.015+6.08%
Post 17:47 ET
4.49MMarket Cap20.83P/E (TTM)
0.310High0.247Low217.03KVolume0.299Open0.291Pre Close57.75KTurnover1.58%Turnover RatioLossP/E (Static)17.97MShares3.39052wk High0.48P/B3.44MFloat Cap0.24752wk Low--Dividend TTM13.78MShs Float9.490Historical High--Div YieldTTM21.81%Amplitude0.247Historical Low0.266Avg Price1Lot Size
About BioNexus Gene Lab Company
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
Company Profile
SymbolBGLC
Company NameBioNexus Gene Lab
Listing DateJul 20, 2023
Founded2017
CEOMr. Lee Su-Leng Tan
MarketNASDAQ
Employees1
Fiscal Year Ends12-31
AddressTower B, Vertical Business Suite,Bangsar South, 8 Jalan Kerinchi,Unit 02, Level 10
CityKuala Lumpur
ProvinceWilayah Perseketuan (Federal Territory)
CountryMalaysia
Zip Code59200
Phone60-3-7421-6898
Company Executives
- Name
- Position
- Salary
- Lee Su-Leng Tan
- President, Chief Executive Officer, Secretary and Director
- 8.00K
- Muhammad Azrul bin Abdul Hamid
- Director
- --
- Jook Yuen Low
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data